Kalu U. E. Ogbureke

Associate ProfessorGeorgia Health Sciences UniversityUnited States of America

Dr. Kalu U. Ogbureke is a tenured Associate Professor at the Georgia Health Sciences University (GHSU) and the Interim Chairman of the Department of Oral Biology, College of Dental Medicine. He holds several joint appointments at GHSU. He is also an Adjunct Professor at the Nebraska Institute of Forensic Sciences. Dr. Ogbureke earned his dental degree from the University of Ibadan, a master’s degree from the University of Glasgow, a doctorate (oral biology) from Harvard University, and a juris doctorate from Suffolk University Law School. He completed the fellowships in dental surgery of the Royal College of Surgeons of England, and the Royal College of Physicians and Surgeons of Glasgow. Dr Ogbureke also completed a postdoctoral fellowship at the National Institute of Health (NIH), Bethesda, Maryland. He is board certified by the American Board of Oral and Maxillofacial Pathology, and a fellow of the Royal College of Pathologists (FRCPath). Dr. Ogbureke is the principal investigator studying the biology of the SIBLING family of proteins in oral cancer through funded grants from NIH. His clinical practice is in diagnostic Oral/Maxillofacial/Head and Neck Pathology.

1books edited

1chapters authored

Latest work with IntechOpen by Kalu U. E. Ogbureke

Oral cancer is a significant public health challenge globally. Although the oral cavity is easily accessible, early diagnosis remains slow compared to the enhanced detection of cancers of the breast, colon, prostate, and melanoma. As a result, the mortality rate from oral cancer for the past four decades has remained high at over 50% in spite of advances in treatment modalities. This contrasts with considerable decrease in mortality rates for cancers of the breast, colon, prostate, and melanoma during the same period. This book attempts to provide a reference-friendly update on the etiologic/risk factors, current clinical diagnostic tools, management philosophies, molecular biomarkers, and progression indicators of oral cancer.

Go to the book